Mycology
(Aug 2024)
Improving treatment of chromoblastomycosis: the potential of COP1T-HA and antimicrobial photodynamic therapy against Fonsecaea monophora In Vitro
Xinyao Liu,
Zhi Zhang,
Jitong Sun,
Renjie Fang,
Xin Ran,
Yuzhou Liu,
Yuping Ran
Affiliations
Xinyao Liu
Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China
Zhi Zhang
Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China
Jitong Sun
Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China
Renjie Fang
ShenYunZhiHe Company, Qidian BLDG, Beijing, China
Xin Ran
Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China
Yuzhou Liu
ShenYunZhiHe Company, Qidian BLDG, Beijing, China
Yuping Ran
Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China
DOI
https://doi.org/10.1080/21501203.2024.2383640
Abstract
Read online
Fonsecaea monophora is one of the common pathogenic species of Chromoblastomycosis (CBM). Antimicrobial photodynamic therapy (aPDT) shows promise as a new treatment for CBM. In this study, we evaluated the effectiveness of COP1T-HA which is a porous organic cage and aPDT against Fonsecaea spp. in vitro.
Keywords
WeChat QR code
Close
